Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annual Review of Genomics and Human Genetics
|
October 7, 2003
Peroxisome biogenesis disorders
Sabine Weller, Stephen J Gould, David Valle
Molecular Genetics and Metabolism
|
November 18, 2023
Newborn screening for adrenoleukodystrophy: International experiences and challenges
Cecilie Videbæk, Lars Melgaard, Allan M Lund, et al.
Journal of Neuroscience Research
|
April 23, 2025
A Novel Mutation in CNTNAP1 Gene Causes Disorganization of Axonal Domains, Hypomyelination and Severe Neurological Deficits
Lacey B Sell, Carson Zabel, Sabine Weller Grønborg, et al.
American Journal of Human Genetics
|
April 29, 2005
Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis
Sabine Weller, Ivelisse Cajigas, James Morrell, et al.
Molecular Genetics and Metabolism Reports
|
June 30, 2026
Arimoclomol in infants with Niemann-Pick disease type C: Results from the phase 2/3 open-label pediatric substudy
Eugen Mengel, Laila Arash-Kaps, Stephanie Grunewald, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
July 27, 2025
A diagnostic algorithm for inherited metabolic disorders using untargeted metabolomics
Qian Gao, Adnan Khan, Mette Christensen, et al.
Molecular Genetics and Metabolism
|
September 14, 2023
X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease
Malene Mejdahl Nielsen, Esben Thade Petersen, Christina Dühring Fenger, et al.
Molecular Genetics and Metabolism
|
July 15, 2025
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial
Eugen Mengel, Rosalia M Da Riol, Mireia Del Toro, et al.
Molecular Genetics and Metabolism Reports
|
June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale
Eugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Neurology
|
June 27, 2025
Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions
Marije A B C Asbreuk, Daphne H Schoenmakers, Laura Ann Adang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annual Review of Genomics and Human Genetics
|
October 7, 2003
Peroxisome biogenesis disorders
Sabine Weller, Stephen J Gould, David Valle
Molecular Genetics and Metabolism
|
November 18, 2023
Newborn screening for adrenoleukodystrophy: International experiences and challenges
Cecilie Videbæk, Lars Melgaard, Allan M Lund, et al.
Journal of Neuroscience Research
|
April 23, 2025
A Novel Mutation in CNTNAP1 Gene Causes Disorganization of Axonal Domains, Hypomyelination and Severe Neurological Deficits
Lacey B Sell, Carson Zabel, Sabine Weller Grønborg, et al.
American Journal of Human Genetics
|
April 29, 2005
Alternative splicing suggests extended function of PEX26 in peroxisome biogenesis
Sabine Weller, Ivelisse Cajigas, James Morrell, et al.
Molecular Genetics and Metabolism Reports
|
June 30, 2026
Arimoclomol in infants with Niemann-Pick disease type C: Results from the phase 2/3 open-label pediatric substudy
Eugen Mengel, Laila Arash-Kaps, Stephanie Grunewald, et al.
Metabolomics : Official Journal of the Metabolomic Society
|
July 27, 2025
A diagnostic algorithm for inherited metabolic disorders using untargeted metabolomics
Qian Gao, Adnan Khan, Mette Christensen, et al.
Molecular Genetics and Metabolism
|
September 14, 2023
X-linked creatine transporter (SLC6A8) deficiency in females: Difficult to recognize, but a potentially treatable disease
Malene Mejdahl Nielsen, Esben Thade Petersen, Christina Dühring Fenger, et al.
Molecular Genetics and Metabolism
|
July 15, 2025
Long-term efficacy and safety of arimoclomol in Niemann-Pick disease type C: Final results of the phase 2/3 NPC-002 48-month open-label extension trial
Eugen Mengel, Rosalia M Da Riol, Mireia Del Toro, et al.
Molecular Genetics and Metabolism Reports
|
June 16, 2025
Efficacy results from a 12-month double-blind randomized trial of arimoclomol for treatment of Niemann-Pick disease type C (NPC): Presenting a rescored 4-domain NPC Clinical Severity Scale
Eugen Mengel, Marc C Patterson, Rosalia M Da Riol, et al.
Neurology
|
June 27, 2025
Metachromatic Leukodystrophy: New Therapy Advancements and Emerging Research Directions
Marije A B C Asbreuk, Daphne H Schoenmakers, Laura Ann Adang, et al.
Page
of 2